Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the detailed record of transactions filed by Behrens M Kathleen, Consejero. Director active across 3 companies, notably Mimedx Group, INC.. In total, 36 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €1.9m. History available since 27 May 2021. The latest transaction was disclosed on 27 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Behrens M Kathleen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20.000 títulos@ 34,92 US$48.8% de su flujoCommon StockSEC:0001209191-22-062287:0
25 de 36 declaraciones
About Behrens M Kathleen
BEHRENS M KATHLEEN is Administrateur at IGM Biosciences, Inc., Sarepta Therapeutics, Inc. and Mimedx Group, INC. She has 36 filings in total, and across the 36 sampled filings from 2021-05-28 to 2026-06-05, purchases total EUR 1851532 and sales total EUR 0. The most common transaction nature is Attribution.